Literature DB >> 34313482

Pancreatic acinar cells utilize tyrosine to synthesize L-dihydroxyphenylalanine.

Guang-Wen Li1, Ji Li1, Xiao-Yan Feng1, Hui Chen1, Ye Chen1, Jing-Hua Liu2, Yue Zhang1, Feng Hong1,3, Jin-Xia Zhu1.   

Abstract

The pancreatic β cells can synthesize dopamine by taking L-dihydroxyphenylalanine, but whether pancreatic acinar cells synthesize dopamine has not been confirmed. By means of immunofluorescence, the tyrosine hydroxylase -immunoreactivity and aromatic amino acid decarboxylase (AADC)- immunoreactivity were respectively observed in pancreatic acinar cells and islet β cells. Treatment with L-dihydroxyphenylalanine, not tyrosine, caused the production of dopamine in the incubation of INS-1 cells (rat islet β cell line) and primary isolated islets, which was blocked by AADC inhibitor NSD-1015. However, only L-dihydroxyphenylalanine, but not dopamine, was detected when AR42J cells (rat pancreatic acinar cell line) were treated with tyrosine, which was blocked by tyrosine hydroxylase inhibitor AMPT. Dopamine was detected in the coculture of INS-1 cells with AR42J cells after treatment with tyrosine. In an in vivo study, pancreatic juice contained high levels of L-dihydroxyphenylalanine and dopamine. Both L-dihydroxyphenylalanine and dopamine accompanied with pancreatic enzymes and insulin in the pancreatic juice were all significantly increased after intraperitoneal injection of bethanechol chloride and their increases were all blocked by atropine. Inhibiting TH with AMPT blocked bethanechol chloride-induced increases in L-dihydroxyphenylalanine and dopamine, while inhibiting AADC with NSD-1015 only blocked the dopamine increase. Bilateral subdiaphragmatic vagotomy of rats leads to significant decreases of L-dihydroxyphenylalanine and dopamine in pancreatic juice. These results suggested that pancreatic acinar cells could utilize tyrosine to synthesize L-dihydroxyphenylalanine, not dopamine. Islet β cells only used L-dihydroxyphenylalanine, not tyrosine, to synthesize dopamine. Both L-dihydroxyphenylalanine and dopamine were respectively released into the pancreatic duct, which was regulated by the vagal cholinergic pathway. The present study provides important evidences for the source of L-dihydroxyphenylalanine and dopamine in the pancreas.

Entities:  

Keywords:  L-DOPA; Pancreatic acinar cells; dopamine; pancreatic juice; physiology; tyrosine hydroxylase

Mesh:

Substances:

Year:  2021        PMID: 34313482      PMCID: PMC8649935          DOI: 10.1177/15353702211032552

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  36 in total

1.  Rasagiline, an inhibitor of MAO-B, decreases colonic motility through elevating colonic dopamine content.

Authors:  C-Z Liu; X-L Zhang; L Zhou; T Wang; Z-S Quan; Y Zhang; J Li; G-W Li; L-F Zheng; L-S Li; J-X Zhu
Journal:  Neurogastroenterol Motil       Date:  2018-06-28       Impact factor: 3.598

2.  Immunocytochemical colocalizations of insulin, aromatic L-amino acid decarboxylase, dopamine beta-hydroxylase, S-100 protein and chromogranin A in B-cells of the chicken endocrine pancreas.

Authors:  M Takayanagi; T Watanabe
Journal:  Tissue Cell       Date:  1996-02       Impact factor: 2.466

3.  Islet proteomics reveals genetic variation in dopamine production resulting in altered insulin secretion.

Authors:  Kelly A Mitok; Elyse C Freiberger; Kathryn L Schueler; Mary E Rabaglia; Donald S Stapleton; Nicholas W Kwiecien; Paige A Malec; Alexander S Hebert; Aimee T Broman; Robert T Kennedy; Mark P Keller; Joshua J Coon; Alan D Attie
Journal:  J Biol Chem       Date:  2018-03-01       Impact factor: 5.157

4.  Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion.

Authors:  Blanca Rubí; Sanda Ljubicic; Shirin Pournourmohammadi; Stefania Carobbio; Mathieu Armanet; Clarissa Bartley; Pierre Maechler
Journal:  J Biol Chem       Date:  2005-08-29       Impact factor: 5.157

5.  Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.

Authors:  Pouria Jandaghi; Hamed S Najafabadi; Andrea S Bauer; Andreas I Papadakis; Matteo Fassan; Anita Hall; Anie Monast; Magnus von Knebel Doeberitz; John P Neoptolemos; Eithne Costello; William Greenhalf; Aldo Scarpa; Bence Sipos; Daniel Auld; Mark Lathrop; Morag Park; Markus W Büchler; Oliver Strobel; Thilo Hackert; Nathalia A Giese; George Zogopoulos; Veena Sangwan; Sidong Huang; Yasser Riazalhosseini; Jörg D Hoheisel
Journal:  Gastroenterology       Date:  2016-08-28       Impact factor: 22.682

6.  Source of dopamine in gastric juice and luminal dopamine-induced duodenal bicarbonate secretion via apical dopamine D2 receptors.

Authors:  Xiao-Yan Feng; Jing-Ting Yan; Guang-Wen Li; Jing-Hua Liu; Rui-Fang Fan; Shi-Chao Li; Li-Fei Zheng; Yue Zhang; Jin-Xia Zhu
Journal:  Br J Pharmacol       Date:  2020-04-12       Impact factor: 8.739

7.  Impaired vagus nerve-mediated control of insulin secretion in Wistar fatty rats.

Authors:  K Yamatani; H Ohnuma; A Niijima; M Igarashi; K Sugiyama; M Daimon; H Manaka; M Tominaga; H Sasaki
Journal:  Metabolism       Date:  1998-10       Impact factor: 8.694

8.  Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models.

Authors:  M K-H Schäfer; N R Hartwig; N Kalmbach; M Klietz; M Anlauf; L E Eiden; E Weihe
Journal:  Diabetologia       Date:  2013-02-13       Impact factor: 10.122

9.  Islet-specific monoamine oxidase A and B expression depends on MafA transcriptional activity and is compromised in type 2 diabetes.

Authors:  Elvira Ganic; Jenny K Johansson; Hedvig Bennet; Malin Fex; Isabella Artner
Journal:  Biochem Biophys Res Commun       Date:  2015-11-10       Impact factor: 3.575

10.  D2-Like Receptors Mediate Dopamine-Inhibited Insulin Secretion via Ion Channels in Rat Pancreatic β-Cells.

Authors:  Mengmeng Liu; Lele Ren; Xiangqin Zhong; Yaqin Ding; Tao Liu; Zhihong Liu; Xiaohua Yang; Lijuan Cui; Lijun Yang; Yanying Fan; Yunfeng Liu; Yi Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-07       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.